EvoNext Holdings S.A.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ELVAF research report →
Companyevonextholdings.com
EvoNext Holdings SA engages in the business of researching, developing, and commercializing novel nutritional, healthcare, and wellness ingredients. The company was founded by Alexandra Santana Sørensen, Søren V. S.
- CEO
- Gerhard Lobmaier
- IPO
- 2021
- Employees
- 49
- HQ
- Reinach, CH
Price Chart
Valuation
- Market Cap
- $8.15M
- P/E
- -14.36
- P/S
- 0.00
- P/B
- 1.58
- EV/EBITDA
- -12.10
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -10.72%
- ROIC
- -11.41%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-653,012 · -162.55%
- EPS
- $-0.09 · -162.29%
- Op Income
- $-678,724
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $1.17
- 52W Low
- $0.90
- 50D MA
- $1.10
- 200D MA
- $0.99
- Beta
- -0.15
- Avg Volume
- 12.851
Get TickerSpark's AI analysis on ELVAF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our ELVAF Coverage
We haven't published any research on ELVAF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ELVAF Report →